According to Hanmi Pharmaceutical 's latest financial reports the company's current earnings are S$0.92 Billion. In 2024 the company made an earning of S$71.22 Million a decrease over its 2023 earnings that were of S$0.13 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | S$0.33 B | 376.42% |
2024 | S$71.22 M | -47.76% |
2023 | S$0.13 B | 79.52% |
2022 | S$75.95 M | 35.13% |
2021 | S$56.2 M | 59.02% |
2020 | S$35.34 M | -13.37% |
2019 | S$40.8 M | 75.79% |
2018 | S$23.21 M | -40.57% |
2017 | S$39.05 M | 59.34% |
2016 | S$24.51 M | -90.55% |
2015 | S$0.25 B | 891.26% |
2014 | S$26.17 M | 89.01% |
2013 | S$13.85 M | -18.07% |
2012 | S$16.9 M |